Evotec SE, DE0005664809

Evotec stock hits a new low as analyst targets split

Published on 09/15/2026 at 14:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evotec stock fell to USD 1.67 on September 14, 2026, after a new 52-week low. MarketBeat shows a USD 3.00 consensus target and Hold rating.

Fotorealistisches Pharma-Labor mit Wissenschaftlern bei Wirkstoffscreening in moderner Biotech-Anlage
Fotorealistisches Pharma-Labor symbolisiert Wirkstoffforschung von Evotec SE, ISIN DE0005664809, moderner Biotech-Standort Hamburg, Illustration mit AI erstellt.

Evotec stock (ISIN DE0005664809) traded at USD 1.67 on September 14, 2026, after touching a new 52-week low of USD 1.67 and closing the prior session at USD 1.73. MarketBeat also put the market value at USD 615.57 million and volume at 4,567 shares.

Analysts keep the range wide

According to MarketBeat, TD Cowen cut Evotec from Buy to Hold and set a USD 2.00 price target on July 15, 2026, while Berenberg downgraded the shares from Buy to Hold on July 16, 2026. The same report said HC Wainwright reduced its target to USD 4.00 from USD 7.00 on July 15, 2026.

That leaves the current target spread broad: MarketBeat said the consensus price target stands at USD 3.00, based on one Buy rating, two Hold ratings and one Sell rating. For investors, the gap between USD 1.67 and USD 3.00 remains the main valuation marker.

Operating trends still matter

MarketBeat said Evotec's short interest increased by 80.21 percent, while the report also showed a debt-to-equity ratio of 0.62, a quick ratio of 2.21 and a current ratio of 2.33. The stock has fallen 43.8 percent from USD 3.08 on January 1, 2026, to USD 1.73 in the MarketBeat snapshot.

MarketBeat also listed expected earnings for Evotec at USD -0.83 per share, rising to USD 0.04 per share in the coming year. That is a clear swing, but it still has to show up in the reported numbers.

Stock stays under pressure

Evotec stock was priced at USD 1.67 on September 14, 2026, with a 52-week range of USD 1.67 to USD 4.27 and a market capitalization of USD 615.57 million. The new low keeps the shares near the bottom of that range.

Evotec stock data

  • Company: Evotec SE
  • ISIN: DE0005664809
  • Ticker: EVO
  • Trading venue: Nasdaq Global Select Market, with a primary listing in Germany
  • Price (as of September 14, 2026): USD 1.67
  • Market capitalization: USD 615.57 million (as of September 15, 2026)
  • Sector / Industry: Healthcare / Life Sciences Tools & Services
  • Index membership: MDAX

More news and analyses on Evotec stock

Disclaimer...

en | DE0005664809 | EVOTEC SE | boerse | 70105230 | bgmi